106.504 articles found

Action and Event-Based Lexical-Semantic Processing in Parkinson's Disease.

Aveni K, McRae K, Borovsky A, Katz B, Roberts A.

Lang Cogn Neurosci · 2025-11-03

DOI: 10.1080/23273798.2025.2580970PMID: 41726863

rs6971 TSPO polymorphism in Parkinson's disease.

Patel B, Camacho M, Evans JR, Breen DP, Foltynie T, Mason SL, Cummins G, Wijeyekoon R, Barker RA, Williams-Gray CH.

Mov Disord · 2025-11-03

DOI: 10.1002/mds.70105PMID: 41178519

Freezing During Swimming as a Precursor to Freezing of Gait in Parkinson's Disease.

Caniça V, Pona-Ferreira F, Guerreiro D, Ferreira JJ.

Mov Disord Clin Pract · 2025-11-03

DOI: 10.1002/mdc3.70423PMID: 41178783

Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression.

LeWitt PA, Li J, Auinger P, Parkinson Study Group DATATOP Investigators.

J Neural Transm (Vienna) · 2025-11-03

DOI: 10.1007/s00702-025-03007-wPMID: 41182351

Tongue Strength and Endurance in Patients with Parkinson's Disease: Association with Swallowing, Oral Phase Efficiency, Meal, Diet Type and Malnutrition Risk.

Mozzanica F, Pizzorni N, Ginocchio D, Feroldi S, Bianchi F, Castellari M, Mora G, Gitto M, Ambrogi F, Schindler A.

Dysphagia · 2025-11-03

DOI: 10.1007/s00455-025-10902-7PMID: 41182362

Gender-associated differences in serum metabolite profiles among patients with Parkinson’s Disease

Marino C, Carrillo F, Nuzzo T, Vidali M, Serra M, Pietracupa S, Modugno N, Grimaldi M, D’Ursi AM, Errico F, Esposito T, Usiello A.

· 2025-11-02

DOI: 10.1101/2025.10.30.25339159

Motor segmentation: a key neuromuscular impairment in people with parkinson's disease.

Daniels RJ, Knight CA.

Exp Brain Res · 2025-11-02

DOI: 10.1007/s00221-025-07189-3PMID: 41176739

The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA.

Leusmann S, Siebs E, Kuhaudomlarp S, Varrot A, Imberty A, Kuhn B, Lerner C, Grether U, Titz A.

Angew Chem Int Ed Engl · 2025-11-02

DOI: 10.1002/anie.202508864PMID: 41178200

Ocular motor dysfunction in patients with multiple system atrophy and Parkinson's disease.

Ling X, Ma X, Wan Z, Sun Y, Li F, Wei L, Li K, Chen J, Zhao G, Kim JS, Yang X, Wang Z.

Clin Neurophysiol · 2025-11-02

DOI: 10.1016/j.clinph.2025.2111413PMID: 41207204

Biallelic RFC1 Expansions Are a Rare Cause of Early-Onset and Familial Parkinson's Disease.

Kovanda A, Šušmelj L, Jaklič H, Lukežič T, Maver A, Petrovic I, Miskovic ND, Svetel M, Rački V, Vuletič V, Novakovic I, Peterlin B.

Clin Genet · 2025-11-02

DOI: 10.1111/cge.70095PMID: 41177915

α-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine

Gao JM, Li WB, Yi Y, Wei JJ, Gong MX, Pan BB, Su XC, Pan YC, Guo DS, Gong QH.

Biomaterials · 2025-11-01

Abstract 372: Rapidly Progressive and Reversible Parkinsonism Secondary to Bilateral Subdural Hematomas

Levinson K.

Stroke (Hoboken, N.J.) · 2025-11-01